S. Pant

发表

Navigating the Rapids: The Development of Regulated Next-Generation Sequencing-Based Clinical Trial Assays and Companion Diagnostics

Russell Weiner, Saumya Pant, M. Marton, 2014, Front. Oncol..

Evaluation of a developmental hierarchy for breast cancer cells to assess risk-based patient selection for targeted treatment

M. Ratajczak, H. Hilton, Neha Sharma, 2018, Scientific Reports.

RG7212 Anti-TWEAK mAb Inhibits Tumor Growth through Inhibition of Tumor Cell Proliferation and Survival Signaling and by Enhancing the Host Antitumor Immune Response

J. Rosinski, H. Hilton, K. Packman, 2013, Clinical Cancer Research.

Cancer Therapy : Preclinical RG 7212 Anti-TWEAK mAb Inhibits Tumor Growth through Inhibition of Tumor Cell Proliferation and Survival Signaling and by Enhancing the Host Antitumor Immune Response

J. Rosinski, H. Hilton, K. Packman, 2013 .

AMPH-1/Amphiphysin/Bin1 functions with RME-1/Ehd in endocytic recycling

K. Patel, S. Caplan, C. Carr, 2009, Nature Cell Biology.

Next Generation Sequencing (NGS)-Repeatability, Reproducibility and accuracy of commercially available Cancer Panels

M. Marton, P. Qiu, John Kang, 2021 .

Validation of Next Generation Sequencing Cancer Panels for Clinical Somatic Mutation Profiling-- Identification of Source of Variations and Artifacts using FFPE Tissues

M. Marton, P. Qiu, John Kang, 2014 .

The multifaceted exosome: Biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities

H. Hilton, M. Burczynski, S. Pant, 2011, Biochemical Pharmacology.

Current Next-Generation Sequencing–Based Companion Diagnostics and Their Analytical Validation

George Green, Michael C. Montalto, Saumya Pant, 2019, Companion and Complementary Diagnostics.

Next-Generation Sequencing–Based Companion Diagnostics: From Biomarker Discovery to Clinical Implementation

George Green, Michael C. Montalto, Saumya Pant, 2019, Companion and Complementary Diagnostics.

Impact of Pre-existing NS5A-L31 or -Y93H Minor Variants on Response Rates in Patients Infected with HCV Genotype-1b Treated with Daclatasvir/Asunaprevir

S. Kirov, S. Pant, F. Mcphee, 2016, Advances in Therapy.

NaV channel variants in patients with painful and nonpainful peripheral neuropathy

R. Freeman, S. Ajroud‐Driss, S. Kirov, 2017, Neurology: Genetics.

Regulation of endocytic recycling by C. elegans Rab35 and its regulator RME‐4, a coated‐pit protein

A. Harada, B. Grant, Miyuki Sato, 2008, The EMBO journal.

A Novel Requirement for C. elegans Alix/ALX-1 in RME-1-Mediated Membrane Transport

B. Grant, S. Pant, Z. Balklava, 2007, Current Biology.

Genome-wide analysis identifies a general requirement for polarity proteins in endocytic traffic

H. Fares, B. Grant, S. Pant, 2007, Nature Cell Biology.

Membrane remodeling by novel regulators of the recycling endosome: the RME-1 and AMPH-1 partnership

S. Pant, 2010 .

Comparison of platforms for determining tumor mutational burden (TMB) from blood samples in patients with non-small cell lung cancer (NSCLC)

S. Kirov, Han Chang, D. Greenawalt, 2019, Annals of Oncology.

Evaluation of a developmental hierarchy for breast cancer cells to assess risk-based patient selection for targeted treatment

M. Ratajczak, H. Hilton, Neha Sharma, 2018, Scientific Reports.

Identification and stratification of systemic lupus erythematosus patients into two transcriptionally distinct clusters based on IFN-I signature

Vivek Jayaswal, V. Shobha, A. Mohan, 2021, Lupus.

Development and Performance of a CD8 Gene Signature for Characterizing Inflammation in the Tumor Microenvironment Across Multiple Tumor Types.

N. Zhang, S. Ely, P. Szabo, 2021, The Journal of molecular diagnostics : JMD.

Validation of next-generation sequencing cancer panels for clinical somatic mutation profilin: Identification of source of variations and artifacts using FFPE tissues.

M. Marton, P. Qiu, John Kang, 2014 .